Back
GT Biopharma Vs. Journey Medical Industry Stock Comparison
Buy
56
GTBP
GT Biopharma
Last Price:
3.83
Seasonality Move:
6.14%
Buy
63
DERM
Journey Medical
Last Price:
3.61
Seasonality Move:
19.11%
Buy
56
GT Biopharma (GTBP)
is a Buy
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $5.02. The Score for GTBP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- GTBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Journey Medical (DERM)
is a Buy
Is Journey Medical a Buy, Sell or Hold?
- The current Journey Medical [DERM] share price is $3.55. The Score for DERM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- DERM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $5.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
DERM Stock Price Chart
What is Journey Medical's stock price today?
-
The Journey Medical share price today is $3.55
The current trend is relatively stagnant and DERM is experiencing buying pressure, which is a positive indicator for future bullish movement.
GTBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 56.9 | Buy |
| Chaikin Money Flow: | 878835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.64 - 4.7) | Buy |
| Bollinger Bands (100): | (3.41 - 6.09) | Buy |
DERM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 49.08 | Sell |
| Chaikin Money Flow: | 36457 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.44 - 3.62) | Buy |
| Bollinger Bands (100): | (3.41 - 4.79) | Sell |
GTBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.29 | Buy |
| 20-day SMA: | 3.66 | Buy |
| 50-day SMA: | 3.96 | Buy |
| 200-day SMA: | 6.15 | Sell |
| 8-day EMA: | 4.64 | Buy |
| 20-day EMA: | 4.05 | Buy |
| 50-day EMA: | 4.09 | Buy |
| 200-day EMA: | 8.2 | Sell |
DERM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.52 | Buy |
| 20-day SMA: | 3.53 | Buy |
| 50-day SMA: | 3.64 | Sell |
| 200-day SMA: | 3.88 | Sell |
| 8-day EMA: | 3.5 | Buy |
| 20-day EMA: | 3.55 | Sell |
| 50-day EMA: | 3.71 | Sell |
| 200-day EMA: | 3.73 | Sell |
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Journey Medical Earnings Growth & DERM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
GT Biopharma Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Journey Medical Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||